Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02461420 · ClinicalTrials.gov registry record
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
A clinical trial of Autism Spectrum Disorder and Intellectual Disability, sponsored by Boston Children's Hospital.
- Active
- Registry status
- 205
- Enrollment target
- 5
- Study locations
NCT02461420 is a study of Autism Spectrum Disorder and Intellectual Disability that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 205 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (53% higher). The trial reports 5 study locations across 5 states.
The verdict
NCT02461420, a study of Autism Spectrum Disorder and Intellectual Disability, is active but no longer recruiting, sponsored by Boston Children's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 205 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to comprehensively characterize PMS using standardized medical, cognitive, and behavioral measures and to track the natural history of the syndrome using repeated longitudinal assessments. In addition, this study will be aiming to identify biomarkers using neuroimaging, including diffusion tensor imaging and identify genetic factors which contribute to diverse phenotypes in patients with PMS.
Conditions Studied
Study Locations (5)
California
- Stanford University - Stanford
Illinois
- Rush University Medical Center - Chicago
Maryland
- National Institutes of Health - Bethesda
Massachusetts
- Boston Children's Hospital - Boston
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2015-05 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02461420
The ClinicalTrials.gov registry entry for NCT02461420 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (53% higher). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT02461420 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Illinois, Maryland.
Frequently Asked Questions
What is clinical trial NCT02461420 about?
NCT02461420 is a clinical study titled "Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome". The purpose of this study is to comprehensively characterize PMS using standardized medical, cognitive, and behavioral measures and to track the natural history of the syndrome using repeated longitudinal assessments. In addition, this study will be aiming to identify biomarkers using neuroimaging, ...
What is the current status of trial NCT02461420?
This trial is currently active not recruiting. The enrollment target is 205 participants. The study started on 2015-05. Estimated completion is 2026-12.
What conditions does trial NCT02461420 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Intellectual Disability, Phelan-McDermid Syndrome.
Who is sponsoring clinical trial NCT02461420?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02461420 being conducted?
This trial has 5 study locations across California, Illinois, Maryland, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.